Abstract: Unglycosylated lysostaphin variant protein, nucleic acid molecule, vector and host cell, as well as a method for production of unglycosylated lysostaphin variant protein in a yeast expression system are provided. The proteins are produced in a Pichia pastoris expression system and have been shown to have activity equivalent to wild-type lysostaphin. The lysostaphin variant proteins can be used as therapeutic proteins for treatment of diseases such as Staphylococcus aureus infection.

Abstract: Compositions comprising deimmunized lysostaphin and methods of using the same, e.g., to treat microbial infection in or on a subject, are provided.

Abstract: Unglycosylated lysostaphin variant protein, nucleic acid molecule, vector and host cell, as well as a method for production of unglycosylated lysostaphin variant protein in a yeast expression system are provided. The proteins are produced in a Pichia pastoris expression system and have been shown to have activity equivalent to wild-type lysostaphin. The lysostaphin variant proteins can be used as therapeutic proteins for treatment of diseases such as Staphylococcus aureus infection.

Abstract: An ultrahigh-pressure acid-fracturing isodiametric hose assembly, comprising a hose body and a metal joint. The metal joint comprises an inner tube, a first outer tube the inner tube, and a second outer tube. The first outer tube and the second outer tube each is an independent pressing part. An external groove is provided at an outer wall of the inner tube. An end of the first outer tube comprises an internal ridge which matches the external groove for snapping. The terminal of the inner tube comprises a connecting portion. An outer wall of the inner tube comprises a first protrusion, and an inner wall of the first outer tube comprises a second protrusion engaging with the first protrusion. The hose body is clamped between the first protrusion and the second protrusion that are engaged. An inner wall of the second outer tube comprises multiple micro-protrusions.

Abstract: Unglycosylated lysostaphin variant protein, nucleic acid molecule, vector and host cell, as well as a method for production of unglycosylated lysostaphin variant protein in a yeast expression system are provided. The proteins are produced in a Pichia pastoris expression system and have been shown to have activity equivalent to wild-type lysostaphin. The lysostaphin variant proteins can be used as therapeutic proteins for treatment of diseases such as Staphylococcus aureus infection.

Abstract: Disclosed are a method for extracting a feature string, a device, a network apparatus, and a storage medium. The method comprises: determining, for each candidate feature string, a transition probability for each pair of adjacent characters in the candidate feature string according to a first-order Markov transition probability matrix; detennining a transition entropy value of the candidate feature string according to the transition probability of each pair of adjacent characters and the logarithm of the transition probability; and labeling a candidate feature string having a transition entropy value greater than a pre-determined threshold as a first usable feature string, and using a valid first usable feature string as an extracted target feature string.

Abstract: Compositions comprising deimmunized lysostaphin and methods of using the same, e.g., to treat microbial infection in or on a subject, are provided.

Abstract: Unglycosylated lysostaphin variant protein, nucleic acid molecule, vector and host cell, as well as a method for production of unglycosylated lysostaphin variant protein in a yeast expression system are provided. The proteins are produced in a Pichia pastoris expression system and have been shown to have activity equivalent to wild-type lysostaphin. The lysostaphin variant proteins can be used as therapeutic proteins for treatment of diseases such as Staphylococcus aureus infection.

Abstract: Compositions comprising deimmunized lysostaphin and methods of using the same, e.g., to treat microbial infection in or on a subject, are provided.

Abstract: Disclosed are a method for extracting a feature string, a device, a network apparatus, and a storage medium. The method comprises: determining, for each candidate feature string, a transition probability for each pair of adjacent characters in the candidate feature string according to a first-order Markov transition probability matrix; determining a transition entropy value of the candidate feature string according to the transition probability of each pair of adjacent characters and the logarithm of the transition probability; and labeling a candidate feature string having a transition entropy value greater than a pre-determined threshold as a first usable feature string, and using a valid first usable feature string as an extracted target feature string.

Abstract: Compositions comprising deimmunized lysostaphin and methods of using the same, e.g., to treat microbial infection in or on a subject, are provided.

Abstract: Compositions comprising deimmunized lysostaphin and methods of using the same, e.g., to treat microbial infection in or on a subject, are provided.

Abstract: Embodiments of the present invention disclose a method and terminal, an input method and device, a cloud service card, and a system for acquiring a service and relate to the field of cloud computing technologies. A method for acquiring cloud service content according to an embodiment of the present invention includes: acquiring, by a cloud terminal, an identifier of a service card; acquiring, by the cloud terminal, a cloud service instruction set corresponding to the identifier of the cloud service card from a cloud instruction set server according to the identifier of the cloud service card; and acquiring, by the cloud terminal, cloud service content from a cloud service server according to a cloud service instruction in the cloud service instruction set. The present invention is applicable to quick acquisition of a latest cloud service provided by an operator.